BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33872192)

  • 1. The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance.
    Nandi A; Chakrabarti R
    Genes Dev; 2020 Nov; 34(21-22):1422-1438. PubMed ID: 33872192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary Development and Breast Cancer: a Notch Perspective.
    Chen W; Wei W; Yu L; Ye Z; Huang F; Zhang L; Hu S; Cai C
    J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):309-320. PubMed ID: 34374886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling in breast cancer: From pathway analysis to therapy.
    Krishna BM; Jana S; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2019 Oct; 461():123-131. PubMed ID: 31326555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance.
    Pandya K; Wyatt D; Gallagher B; Shah D; Baker A; Bloodworth J; Zlobin A; Pannuti A; Green A; Ellis IO; Filipovic A; Sagert J; Rana A; Albain KS; Miele L; Denning MF; Osipo C
    Clin Cancer Res; 2016 Jan; 22(1):175-86. PubMed ID: 26350262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance.
    Chimento A; D'Amico M; Pezzi V; De Amicis F
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.
    Liu H; Wang J; Zhang M; Xuan Q; Wang Z; Lian X; Zhang Q
    Breast Cancer Res Treat; 2017 Nov; 166(1):95-107. PubMed ID: 28730338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling as a therapeutic target for breast cancer treatment?
    Han J; Hendzel MJ; Allalunis-Turner J
    Breast Cancer Res; 2011 May; 13(3):210. PubMed ID: 21672271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch-out for breast cancer therapies.
    Lamy M; Ferreira A; Dias JS; Braga S; Silva G; Barbas A
    N Biotechnol; 2017 Oct; 39(Pt B):215-221. PubMed ID: 28842360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
    Bui QT; Im JH; Jeong SB; Kim YM; Lim SC; Kim B; Kang KW
    Cancer Lett; 2017 Apr; 390():115-125. PubMed ID: 28108315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer.
    Pandey P; Khan F; Choi M; Singh SK; Kang HN; Park MN; Ko SG; Sahu SK; Mazumder R; Kim B
    Biomed Pharmacother; 2023 Aug; 164():114938. PubMed ID: 37267635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab resistance: role for Notch signaling.
    Mehta K; Osipo C
    ScientificWorldJournal; 2009 Dec; 9():1438-48. PubMed ID: 20024517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.
    García-Becerra R; Santos N; Díaz L; Camacho J
    Int J Mol Sci; 2012 Dec; 14(1):108-45. PubMed ID: 23344024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling and its role in breast cancer.
    Wu F; Stutzman A; Mo YY
    Front Biosci; 2007 May; 12():4370-83. PubMed ID: 17485381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
    Kakarala M; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch in mammary gland development and breast cancer.
    Politi K; Feirt N; Kitajewski J
    Semin Cancer Biol; 2004 Oct; 14(5):341-7. PubMed ID: 15288259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling proteins: legitimate targets for cancer therapy.
    Wang Z; Li Y; Sarkar FH
    Curr Protein Pept Sci; 2010 Sep; 11(6):398-408. PubMed ID: 20491628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.